Mounjaro®
Starting from £179.99/mo
Start journey Learn moreA faster-than-usual heart rate is a recognised side effect of tirzepatide (Mounjaro). Clinical trial data and the medicine's SmPC both document a modest rise in resting heart rate in some people, typically a small increase of around a few beats per minute. For most people it is mild and settles, but knowing when to act on it matters. Mounjaro is a prescription-only medicine; any concerns about how your heart is responding should go to your prescribing clinician, not to a forum.
At your door the next working day.
Free, tracked, plain packaging.
BMI isn't the whole story, but it's where clinicians start. Check yours in ten seconds — nothing is stored, nothing is shared.
Ten seconds. Private — nothing is stored or shared.
Your result updates live in the card alongside.
Your result
Your BMI is
—
which is in the healthy weight range
Start journeyBMI doesn't determine eligibility — only a clinician can assess whether treatment is right for you.
The problem
The nume way
clinician review. Free next working day delivery.
How it works
Tell us about your health, history and goals. Free, online, and confidential — no commitment, no waiting room.
Our team reviews your health the same day — never an algorithm, and approves your treatment there and then if eligible.
Order by 12pm, dispatched same day, delivered free the next working day — the nume Promise.
The GIP and GLP-1 receptors that tirzepatide activates are found not just in the gut and brain but in cardiac tissue too. Stimulating these receptors appears to produce a small chronotropic effect (meaning the heart beats slightly faster) in some people. This is not unique to Mounjaro; a similar pattern is seen across the broader GLP-1 medicine class. The Mounjaro overview explains the dual-receptor mechanism in more detail if you want the background on how tirzepatide works.
Importantly, this is distinct from a dangerous arrhythmia. What most people notice (if they notice anything) is a pulse that sits a handful of beats per minute above their usual baseline. That said, individual responses vary considerably, and a rise that is trivial for one person can feel very noticeable for another, particularly anyone who is sensitive to physical symptoms or who is monitoring closely with a smartwatch. For a deeper look at the proposed mechanism behind this specific effect, our page on why Mounjaro raises heart rate covers the physiology in full.
Dehydration deserves a mention here too. Nausea and vomiting, which are among the most common early side effects of tirzepatide, can reduce fluid intake and push heart rate up independently of anything the medicine itself is doing to cardiac receptors. If your pulse feels elevated and you have also been struggling with GI symptoms, rehydration is the first practical step, and then reassess. The NHS's patient guidance on tirzepatide side effects is worth reading alongside the leaflet that came with your pen.
This is the question most people are actually asking when they search this topic. The honest answer has two parts.
For a mildly elevated resting heart rate with no other symptoms, the usual clinical approach is to give it time, particularly in the first two to four weeks of a new dose. The effect often settles as your body adjusts. Staying hydrated, avoiding large quantities of caffeine, and keeping your prescriber in the loop at your next review is generally appropriate. If you are on the starting 2.5 mg dose, this adjustment window applies — the purpose of that initial pen is to let your body acclimatise before any step-up is considered. Our page on when to increase your Mounjaro dose gives context on how and why the schedule is paced the way it is.
Seek medical attention promptly if you experience: a heart rate that is consistently very high (above 100 bpm at rest) and not explained by exertion or illness; palpitations accompanied by chest tightness, breathlessness or dizziness; or any fainting or near-fainting. These symptoms go beyond the small background effect seen in trials and need clinical assessment the same day, not a prescription renewal. Call 111 or see your GP; if symptoms are severe, call 999.
People with a pre-existing heart rhythm condition should have discussed Mounjaro's cardiac effects with their prescriber before starting. If that conversation didn't happen, now is the time to have it.
An elevated heart rate that persists, or that worsens at each dose increase, is clinically relevant information for your prescriber. It may influence whether your next step-up goes ahead on schedule, is delayed, or (in rare cases) whether a different treatment approach is considered. That is precisely the kind of conversation a prescriber weighs up; it is not a decision you should make by adjusting your dose yourself.
If you are thinking about a dose change anyway, the pages on why doses are increased and how dose increases work set out the clinical rationale clearly. And if you are comparing tirzepatide with other treatment options, our weight-loss treatment overview gives a broader view.
One practical note: if your review is due around a bank holiday or a month where you ordered later than usual, the timing gap can feel longer. Mounjaro is available for same-day dispatch at the current treatment price when ordered by midday on a weekday, but any dose change still needs a prescriber's sign-off first, regardless of when the order lands.
Some people also notice other unexpected changes during treatment. An increase in libido, for instance, has been reported anecdotally and is discussed on our page about Mounjaro and libido changes for those curious about that side of the picture.
If you have unresolved questions or want your heart-rate pattern reviewed by a clinician who knows your history, our team is available seven days a week. Speak to our prescribers through a free consultation, a real clinician reads every submission, not an automated system.
The people
Superintendent Pharmacist (GPhC No. 2217101)
Accountable for the safe running of our registered pharmacy, from every dispensing check to every dispatch.
Clinical Lead (GPhC No. 2231744)
Sets our clinical standards and checks everything we publish against current MHRA guidance.
Independent Prescriber (GPhC No. 2084501)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.
Independent Prescriber (GPhC No. 2083426)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.